Actively Recruiting
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
Led by Centre Hospitalier Universitaire de la Guadeloupe · Updated on 2025-12-05
10
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.
CONDITIONS
Official Title
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of dermatomyositis according to the 2003 ENMC criteria
- Parents or grandparents originating from the Caribbean arc
- Age 16 years or older
- Resident of Guadeloupe
- Provided informed consent (or legal representative consent)
- Affiliated with a social security scheme
You will not qualify if you...
- Started treatment with intravenous immunoglobulins, corticosteroids, or immunosuppressants within one month before diagnosis
- Under legal protection (guardianship or trusteeship) or deprived of liberty
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de la Guadeloupe
Pointe-à-Pitre, Guadeloupe, 97139
Actively Recruiting
Research Team
M
melanie petapermal, Master degree
CONTACT
V
Valérie Hamony Soter
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here